Pharmafile Logo

Latest wave of Therapy Watch IBD to run this month

November 23, 2016 | IBD, autoimmune disease, therapy watch 

The IBD syndicated market tracker is part of our large auto-immune portfolio

This month, Therapy Watch IBD will be running in the 5 EU markets of France, Germany, Italy, Spain and the UK. A panel of 200 gastroenterologists will report in 10 IBD patient record forms each quarter (5 Crohn’s disease and 5 ulcerative colitis), to monitor the evolving IBD treatment landscape.

http://www.researchpartnership.com/news/2016/08/latest-wave-of-therapy-watch-ibd-to-run-this-month/

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Infographic: Spondyloarthritis

Overview of spondyloarthritis patient profiles and treatment pathways.

Webinar: Demand assessment – Reflecting real world choices

How study design which reflects doctors’ real world choices can optimise results.

Evaluating the potential of a pre-launch prodct in a real-life setting

Using in-depth-interviews as well as a SmartPhone app to collect real patient cases from physicians to find out opportunity for a new product.

Competition from within

Published in eyeforpharma July 29 by Rachel Howard

Infographic: RA Perceptions

HCPs predict the future of the biologics market

From chaos to calm: how to make sense of social media

What do you know about chaos theory?

Breaking Down the Barriers to Effective Treatment of Hepatitis C in Latin America

Published in eyeforpharma June 9 by Rachel Howard and Raquel Nunez.

Infographic: HCV LATAM

An introduction to the HCV LATAM patient.

Spotlight on Saudi Arabia

Published in eyeforpharma 20 May by Rachel Howard